ATP1A1 and osteosarcoma: Collectively, the results provide novel insights into the post‐transcriptional regulation of ATP1A1 by LncDARS‐AS1 and identify both molecules as promising candidates for therapeutic intervention and prognostic stratification in osteosarcoma.